Search

Kira Radinsky’s Diagnostic Robotics raises $45 million Series B

ORIGINALLY PUBLISHED BY CTECH


The Israeli startup, which has developed an AI platform that helps predict which patients will benefit from proactive interventions and improve the point of care, has doubled its valuation to several hundred million dollars since its last funding round in 2019


"Kira Radinsky’s latest startup Diagnostic Robotics, which has developed an AI platform that helps predict which patients will benefit from proactive interventions and improve the point of care, has raised $45 million in a Series B funding round. Radinsky co-founded Diagnostic Robotics with Yonatan Amir and Prof. Moshe Shoham in 2017. Radinsky serves as the company’s CEO, while Amir holds the role of President, and Shoham, the former founder of Mazor Robotics sold to Medtronic for $1.6 billion in 2018, is the company’s Engineering Director...


According to Radinsky, Diagnostic was valued at several hundred million dollars in the round. “Companies aren’t rushing to be unicorns anymore. The joke going around is that everyone wants to be cockroaches, as in a creature that survives,” Radinsky joked in an interview with Calcalist.


“Even though I’m an expert in predictions, I didn’t predict what happened and started the funding round just as the market collapsed, which made everything far from trivial,” said Radinsky. “There is always a war or a crisis somewhere and it is part of the role of an entrepreneur to deal with these situations. At the moment many investors prefer to wait and see what will happen to the markets and only talk then. This round was very different from the previous ones I raised.”


Diagnostic Robotics, which employs around 60 people and will use the funding to recruit additional marketing and sales staff, develops predictive analytics models to address pressing clinical and financial challenges in healthcare. The company's solutions enable healthcare systems to deliver more-effective care at lower costs. Diagnostic Robotics' suite of products is currently in use at healthcare institutions, HMOs, and providers in Israel and the United States..."


Read Full Article >